Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women

Diabetes Care

Volumn 28, Issue 6, 2005, Pages 1438-1444

  Song, Yiqing ^a,b   Ridker, Paul M ^a   Manson, JoAnn E ^a,b   Cook, Nancy R ^a,b   Buring, Julie E ^a,b,c   Liu, Simin ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; MAGNESIUM;

ADULT; AGED; ARTICLE; BODY MASS; CANCER; CARDIOVASCULAR DISEASE; DIET; FEMALE; HUMAN; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MINERAL INTAKE; RISK ASSESSMENT; SMOKING; UNITED STATES;

ALCOHOL DRINKING; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIET; ENERGY INTAKE; EXERCISE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAGNESIUM; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; UNITED STATES;

EID: 19944384589     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.6.1438     Document Type: Article

References (35)

1. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A: Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 294:1-26, 2000
2. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo A, Paolisso G: Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 24: 39-52, 2003
3. Paolisso G, Barbagallo M: Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 10:346-355, 1997
4. Fung TT, Manson JE, Solomon CG, Liu S, Willett WC, Hu FB: The association between magnesium intake and fasting insulin concentration in healthy middle-aged women. J Am Coll Nutr 22:533-538, 2003
5. Song Y, Manson JE, Buring JE, Liu S: Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27:59-65, 2004
6. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC: Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20:545-550, 1997
7. Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE: Diet and risk of clinical diabetes in women. Am J Clin Nutr 55:1018-1023, 1992
8. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, Yano K, Curb JD: Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 92:665-669, 2003
9. Al-Delaimy WK, Rimm EB, Willett WC, Stampfer MJ, Hu FB: Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23:63-70, 2004
10. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, Witteman J, Stampfer MJ: Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27:1065-1072, 1996
11. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ: A prospective study of nutritional factors and hypertension among US men. Circulation 86:1475-1484, 1992
12. Nadler JL, Buchanan T, Natarajan R, Antomipillai I, Bergman R, Rude R: Magnesium deficiency produces insulin resistance and increased thromboxan synthesis. Hypertension 21:1024-1029, 1993
13. Paolisso G, Ravusin E: Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J Clin Endocrinol Metab 80:1382-1385, 1995
14. Altura BM, Altura BT: Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 41:347-359, 1995
15. Rasmussen HS, Aurup P, Goldstein K, McNair P, Mortensen PB, Larsen OG, Lawaetz H: Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease: a doubleblind, placebo controlled study. Arch Intern Med 149:1050-1053, 1989
16. Touyz RM: Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 24:107-136, 2003
17. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S: Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 238:163-179, 2002
18. Bassuk SS, Rifai N, Ridker PM: High-sensitivity C-reactive protein. Curr Probl Cardiol 29:439-493, 2004
19. Buring JE, Hennekens CH: The Women's Health Study: summary of the study design. J Myocard Ischemia 4:27-29, 1992
20. Liu S, Buring JE, Sesso HD, Rimm EB, Willett WC, Manson JE: A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol 39:49-56, 2002
21. Watt BK, Merrill AL: Composition of Foods: Raw, Processed, Prepared, 1963-1992: Agriculture Handbook no. 8. Washington, DC, U.S. Department of Agriculture, 1993
22. Willett WC, Stampfer MJ: Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17-27, 1986
23. Willett WC: Nutritional Epidemiology. New York, Oxford University Press, 1998
24. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397, 2003
25. Song Y, Manson JE, Buring JE, Liu S: A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the Women's Health Study. Diabetes Care 27:2108-2115, 2004
26. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002
27. Rifai N, Ridker PM: Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 49:666-669, 2003
28. Council NR: Recommended Dietary Allowances. 10th ed. Washington, DC, National Academy of Sciences Press, 1989
29. Guerrero-Romero F, Rodriguez-Moran M: Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 26: 469-474, 2002
30. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W: Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23:1835-1839, 2000
31. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380-385, 2004
32. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT: C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47:1403-1410, 2004
33. Wilson PW, Grundy SM: The metabolic syndrome: practical guide to origins and treatment: part I. Circulation 108:1422-1424, 2003
34. Wilson PW, Grundy SM: The metabolic syndrome: a practical guide to origins and treatment: part II. Circulation 108:1537-1540, 2003
35. Guerrero-Romero F, Rodriguez-Moran M: Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39:209-213, 2002